On Monday, November 20, 2017, a 33-year-old resident of Corpus Christi, Texas was ordered to prison after being convicted of possessing a controlled substance with the intent to distribute as well as receiving a misbranded drug in interstate commerce. Elias Trevino Jr. previously pleaded guilty on May 15, 2017. Trevino was sentenced to 12 months in prison.
In 1997, the FDA approved sibutramine for the management of obesity. It was marketed under the trade name Meridia. In October of 2010, the FDA requested the marketer of Meridia to withdraw the drug from the United States due to health risks. In December of 2010, the FDA followed the manufacturer’s request and withdrew its approval of Meridia. Since that point, no medication containing sibutramine had been approved for human used in the United States.
Trevino confessed to knowingly possessing and selling diet drugs containing sibutramine. He admitted to importing the drugs from China and selling them online and through his Corpus Christi vitamin store, X2Zero. Elias Trevino Jr. was one of the owners of the X2Zero store. He was previously released on bond, but was taken back into custody following today’s sentencing.
The defendant will remain pending transfer to a United States BOP facility, which will be determined in the future. More details can be found here.